Rx · PZN 00183928, 03037794
LEVO-C AL 200 mg/50 mg prolonged-release tablets
German trade nameLEVO-C AL 200 mg-50 mg Retardtabletten
Only sporadically available
2.9out of 10
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for LEVO-C AL 200 mg/50 mg prolonged-release tablets.
Review purchasing termsLEVO-C AL 200 mg/50 mg prolonged-release tablets contains the active ingredient Levodopa and decarboxylase inhibitor (German Levodopa und Decarboxylasehemmer*) and comes as Prolonged-release tablets. 2 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 1.6 to 2.9 out of 10. The best-available pack was only sporadically available.
Pack sizes · 2 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 00183928 | 2.7 | 2.9 | ~ €40 |
| 03037794 | 1.3 | 1.6 | ~ €73 |
LEVO-C AL 200 mg/50 mg prolonged-release tablets was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.
Request a source of supply